EcoDrugPlus

Matrix Metallopeptidase 2

Ensembl ID : ENSSTOG00000022615
Gene Symbol: MMP2
4 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSSTOG00000008584
Gene Symbol: MMP3
4 Cross references
492 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSSTOG00000027961
Gene Symbol: MMP7
3 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSSTOG00000008539
Gene Symbol: MMP8
4 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSSTOG00000006380
Gene Symbol: MMP9
3 Cross references
214 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSSTOG00000005494
Gene Symbol: MTOR
4 Cross references
214 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSSTOG00000022025
Gene Symbol: MC3R
3 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSSTOG00000026368
Gene Symbol: MC4R
3 Cross references
121 Possible Orthologues:

Melanocyte-Stimulating Hormone Receptor-Like

Ensembl ID : ENSSTOG00000032206
Gene Symbol: LOC101962180
2 Cross references
158 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSSTOG00000020582
Gene Symbol: MTNR1A
4 Cross references
205 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSSTOG00000008849
Gene Symbol: MTNR1B
4 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSSTOG00000000081
Gene Symbol: MME
4 Cross references
236 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).